KPTI Karyopharm Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$0,80
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,7552 haftanın en düşüğü
$10,9952 haftanın en yükseği
Piyasa Değeri (MRQ)
$18M
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-14.40
Gelir (TTM)
$147M
rozetleriniz
52 Haftlık Aralık
$1–$11
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$7
P/E
-0.1
ROE
79.0%
Net Kâr Marjı
-153.3%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
KPTI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.80
Piyasa Değeri (MRQ)
$18M
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-14.40
Gelir (TTM)
$147M
ROE (TTM)
79.0%
52 Haftlık Aralık
$1–$11
KPTI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 26 Şubat 2025 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$146M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-17.932020-12-31 → 2025-12-31
Serbest Nakit Akışı$-75M2016-12-31 → 2025-12-31
Net kar marjı-153.3%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | KPTI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.15Y ort. ≈-17.1 | ≈-17.1 | · | · | |
| F/S (TTM) | 0.15Y ort. ≈18.3 | ≈18.3 | · | · | |
| F/D (MRQ) | -0.15Y ort. ≈-91.3 | ≈-91.3 | · | · | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -0.25Y ort. ≈-26.9 | ≈-26.9 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -0.25Y ort. ≈-26.9 | ≈-26.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | KPTI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -56.2%5Y ort. ≈-74.1% | ≈-74.1% | -3881.8% | En üst düzey | |
| EBITDA Margin (FAVÖK Marjı) | -62.1%5Y ort. ≈-74.1% | ≈-74.1% | -3881.8% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -153.3%5Y ort. ≈-89.7% | ≈-89.7% | -6642.7% | En üst düzey | |
| Net Kâr Marjı (TTM) | -153.3%5Y ort. ≈-89.8% | ≈-89.8% | -4978.6% | En üst düzey | |
| ROA (TTM) | -207.9%5Y ort. ≈-63.8% | ≈-63.8% | -78.1% | Zayıf | |
| ROE (TTM) | 79.0%5Y ort. ≈114.0% | ≈114.0% | -107.8% | En üst düzey | |
| ROIC | 31.0%5Y ort. ≈234.0% | ≈234.0% | 29.5% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | KPTI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 0.85Y ort. ≈3.0 | ≈3.0 | 2.0 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.95Y ort. ≈1.7 | ≈1.7 | 1.4 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | KPTI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 0.57%5Y ort. ≈12.4% | ≈12.4% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -2.4%5Y ort. ≈-1.1% | ≈-1.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 6.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | KPTI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.15Y ort. ≈0.7 | ≈0.7 | 0.0 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 5.15Y ort. ≈6.1 | ≈6.1 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$640.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-10.1%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-2.32 | $-1.30 | -78.2% |
| 31 Mart 2026 | May 14, 2026 | $-1.24 | $-1.46 | 14.9% |
| 31 Aralık 2025 | $-2.22 | $-2.03 | -9.1% | |
| 30 Eylül 2025 | $-3.82 | $-3.19 | -19.6% | |
| 30 Haziran 2025 | $-4.32 | $-4.18 | -3.3% | |
| 31 Mart 2025 | $-2.77 | $-4.26 | 35.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $146M | $145M | $146M | $157M | $210M | $108M | $41M | $30M | $2M | $154.0K | $250.0K | $229.0K | |
| R&D Expense | $126M | $143M | $139M | $149M | $161M | $151M | $122M | $161M | $107M | $87M | $98M | $60M | |
| SG&A Expense | $105M | $115M | $132M | $145M | $144M | $126M | $105M | $49M | $25M | $24M | $22M | $16M | |
| Operating Expenses | $237M | $265M | $276M | $299M | $308M | $280M | $230M | $210M | $132M | $111M | $119M | $76M | |
| Operating Income | $-91M | $-119M | $-130M | $-142M | $-98M | $-172M | $-189M | $-180M | $-131M | $-111M | $-119M | $-76M | |
| Interest Expense | · | · | $24M | $25M | $26M | $27M | $16M | $2M | · | · | · | $1.0K | |
| Interest Income | $3M | $7M | $11M | $2M | $582.0K | $3M | $5M | $4M | $2M | $1M | $897.0K | $97.0K | |
| Other Non-op | $152.0K | $28M | $-356.0K | $-83.0K | $-85.0K | $206.0K | $-50.0K | $-33.0K | $-81.0K | $10.0K | $-2.0K | $-27.0K | |
| Pretax Income | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-109M | $-118M | $-76M | |
| Income Tax | $43.0K | $57.0K | $323.0K | $369.0K | $268.0K | $309.0K | $40.0K | $26.0K | $63.0K | $139.0K | $-118M | $-76M | |
| Net Income | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-110M | $-118M | $-76M | |
| EPS (Basic) | $-17.93 | $-9.41 | $-18.79 | $-2.02 | $-1.65 | $-2.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.93 | $-14.00 | $-18.79 | $-2.02 | $-1.65 | $-2.72 | · | · | · | · | · | · | |
| Shares (Basic) | 10,935 | 8,125 | 7,616 | 81,871 | 75,218,000 | 72,044,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 10,935 | 8,455 | 7,616 | 81,871 | 75,218,000 | 72,044,000 | · | · | · | · | · | · | |
| EBITDA | $-91M | $-119M | $-130M | $-142M | $-98M | $-172M | $-189M | $-180M | $-131M | $-111M | $-119M | $-76M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $62M | $52M | $135M | $190M | $86M | $129M | $118M | $69M | $50M | $58M | $151M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $77M | $80M | $117M | $55M | |
| Receivables | $26M | $31M | $27M | $47M | $22M | $13M | $8M | · | · | · | · | · | |
| Inventory | $4M | $5M | $3M | $4M | $4M | $3M | $346.0K | · | · | · | · | · | |
| Prepaid Expense | $9M | $12M | $12M | $20M | $14M | $9M | $7M | $6M | $2M | $2M | $2M | $2M | |
| Other Current Assets | · | · | · | · | $2M | · | · | · | · | · | · | · | |
| Current Assets | $103M | $156M | $234M | $350M | $276M | $277M | $279M | $335M | $148M | $132M | $178M | $208M | |
| PP&E (Net) | $104.0K | $400.0K | $606.0K | $1M | $2M | $2M | $3M | $4M | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $7M | $7M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $5M | $3M | |
| Accum. Depreciation | $6M | $7M | $7M | $7M | $6M | $5M | $4M | $3M | $3M | $2M | $1M | $494.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $774.0K | |
| Total Assets | $108M | $164M | $240M | $358M | $305M | $313M | $295M | $341M | $180M | $180M | $215M | $220M | |
| Accounts Payable | $4M | $5M | $3M | $3M | $2M | $4M | $985.0K | $4M | $6M | $5M | $4M | $6M | |
| Accrued Liabilities | $64M | $61M | $61M | $58M | $69M | $53M | $41M | $32M | $21M | $11M | $11M | $6M | |
| Current Liabilities | $92M | $92M | $69M | $66M | $74M | $60M | $46M | $47M | $49M | $16M | $15M | $12M | |
| Capital Leases | $6M | $7M | $3M | $6M | $9M | $11M | $13M | · | · | · | · | · | |
| Other Non-current Liabilities | $11M | $2M | $978.0K | $0 | · | · | · | · | · | · | · | · | |
| Total Liabilities | $401M | $350M | $377M | $375M | $385M | $263M | $245M | $158M | $51M | $18M | $17M | $14M | |
| Long-term Debt | · | · | · | · | $169M | · | · | · | · | · | · | · | |
| Common Stock | $14.0K | $13.0K | $12.0K | $12.0K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $345M | |
| Retained Earnings | $-1.76B | $-1.56B | $-1.49B | $-1.34B | $-1.18B | $-1.07B | $-873M | $-674M | $-495M | $-366M | $-257M | $-138M | |
| AOCI | $71.0K | $-356.0K | $-161.0K | $-638.0K | $191.0K | $518.0K | $-37.0K | $-244.0K | $-217.0K | $-274.0K | $-282.0K | $-29.0K | |
| Stockholders' Equity | $-293M | $-186M | $-136M | $-17M | $-80M | $51M | $50M | $183M | $129M | $162M | $198M | $207M | |
| Liabilities + Equity | $108M | $164M | $240M | $358M | $305M | $313M | $295M | $341M | $180M | $180M | $215M | $220M | |
| Shares Outstanding | 18,311,000 | 8,413,000 | 114,915,000 | 113,213,000 | 75,746,000 | 73,923,000 | 65,370,000 | 60,829,308 | 49,533,150 | 41,887,829 | 35,864,765 | 32,699,380 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $974.0K | $735.0K | $713.0K | $717.0K | $634.0K | $323.0K | |
| Stock-based Comp | $14M | $18M | $22M | $35M | $30M | $24M | $15M | $17M | $20M | $22M | $17M | $14M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Operating Cash Flow | $-75M | $-127M | $-93M | $-150M | $-107M | $-160M | $-191M | $-159M | $-74M | $-84M | $-94M | $-51M | |
| CapEx | $0 | $142.0K | $0 | $118.0K | $212.0K | $145.0K | $206.0K | $2M | $62.0K | $70.0K | $1M | $3M | |
| Investing Cash Flow | $43M | $95M | $8M | $-104M | $142M | $-54M | $78M | $-108M | $17M | $25M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $113M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | $113M | |
| Financing Cash Flow | $30M | $42M | $1M | $194M | $74M | $172M | $124M | $316M | $76M | $51M | · | · | |
| Net Change in Cash | $-2M | $10M | $-84M | $-61M | $108M | $-42M | $12M | $49M | $19M | $-9M | $-92M | $-5M | |
| Free Cash Flow | $-75M | $-128M | $-93M | $-150M | $-107M | $-160M | $-191M | $-161M | $-74M | $-84M | $-95M | $-54M | |
| Levered FCF | · | · | $-117M | $-175M | $-133M | $-188M | $-207M | $-164M | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.8% | -593.0% | · | -71903.9% | -47630.4% | -33120.5% | |
| Net Margin | -134.2% | -52.6% | -98.0% | -105.2% | -59.1% | -181.6% | -488.1% | -588.1% | · | -71153.9% | -47272.4% | -33090.4% | |
| Pretax Margin | -134.2% | -52.6% | -97.8% | -105.0% | -59.0% | -181.3% | -488.0% | -588.0% | · | -71063.6% | · | · | |
| EBITDA Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.8% | -593.0% | · | -71903.9% | -47630.4% | -33120.5% | |
| ROA | -143.7% | -37.8% | -47.8% | -49.8% | -40.1% | -64.6% | -62.7% | -68.4% | -71.5% | -55.4% | -54.2% | -40.0% | |
| ROE | 73.7% | 44.2% | 121.0% | 210.7% | 120.7% | -292.3% | -364.1% | -100.7% | -88.4% | -60.8% | -58.3% | -41.9% | |
| ROIC | 31.0% | 64.3% | 95.3% | 855.7% | 123.6% | -340.5% | -380.4% | -98.2% | -100.9% | -68.3% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.7 | 3.4 | 5.3 | 3.7 | 4.6 | 6.0 | 7.1 | 3.0 | 8.0 | 11.7 | 16.9 | |
| Quick Ratio | 0.9 | 1.0 | 1.1 | 2.8 | 2.9 | 1.6 | 2.9 | 2.5 | 3.0 | 7.9 | 11.6 | 16.7 | |
| Interest Coverage | · | · | -5.4 | -5.7 | -3.8 | -6.3 | -12.1 | -72.2 | · | · | · | -75846.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 0.7 | 0.5 | 0.5 | 0.7 | 0.4 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 5.1 | 5.0 | 3.9 | 4.5 | 11.9 | 10.4 | 10.4 | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-16.00 | $-1.47 | $-1.19 | $-0.15 | $-1.05 | $0.68 | $0.76 | $3.01 | $2.61 | $3.87 | $5.53 | $6.32 | |
| Revenue / Share | $13357.75 | $1145.32 | $1.28 | $1.92 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-6892.46 | $-1005.34 | $-0.81 | $-1.83 | · | · | · | · | · | · | · | · | |
| Cash / Share | $3.31 | $0.50 | $0.45 | $1.19 | $2.51 | $1.16 | $1.97 | $1.94 | $1.39 | $1.19 | $1.63 | $4.61 | |
| EPS (TTM) | $-17.93 | $-14.00 | $-18.79 | $-2.02 | $-1.65 | $-2.72 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.57% | -0.55% | -7.0% | -25.1% | 94.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -11.5% | 10.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.2% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $146M | $145M | $146M | $157M | $210M | $108M | $41M | $30M | $2M | $154.0K | $250.0K | $229.0K | |
| Net Income TTM | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-110M | $-118M | $-76M | |
| Market Cap | $135M | $1.28B | $1.49B | $5.77B | $7.31B | $17.16B | $18.80B | $8.55B | $7.13B | $5.91B | $7.13B | $18.36B | |
| P/E | -0.4 | -0.7 | -0.7 | -25.2 | -58.5 | -85.4 | · | · | · | · | · | · | |
| P/S | 0.9 | 8.8 | 10.2 | 36.8 | 34.8 | 158.8 | 459.7 | 281.8 | 4444.1 | 38351.8 | 28512.5 | 80170.6 | |
| P/B | -0.5 | -6.9 | -10.9 | -346.7 | -91.7 | 339.6 | 377.7 | 46.7 | 55.1 | 36.4 | 35.9 | 88.8 | |
| P / Tangible Book | · | · | · | · | · | 339.6 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -10.0 | -16.1 | -38.6 | -68.2 | -107.1 | -98.5 | -53.7 | -96.8 | -70.0 | -75.8 | -356.9 | |
| P / FCF | -1.8 | -10.0 | -16.1 | -38.6 | -68.1 | -107.0 | -98.4 | -52.9 | -96.7 | -69.9 | -74.7 | -338.2 | |
| Earnings Yield | -243.6% | -138.1% | -144.8% | -4.0% | -1.7% | -1.2% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $35M | $34M | $44M | $38M | $30M | $31M | $39M | $43M | $33M | $34M | $36M | $38M | $39M | $34M | $36M | |
| R&D Expense | $29M | $34M | $28M | $31M | $33M | $35M | $33M | $36M | $38M | $35M | $39M | $36M | $31M | $32M | $31M | $31M | |
| SG&A Expense | $26M | $27M | $23M | $27M | $28M | $27M | $27M | $28M | $31M | $30M | $31M | $31M | $34M | $36M | $35M | $35M | |
| Operating Expenses | $56M | $62M | $52M | $59M | $62M | $63M | $62M | $65M | $71M | $67M | $72M | $67M | $67M | $70M | $67M | $67M | |
| Operating Income | $-23M | $-27M | $-18M | $-15M | $-24M | $-33M | $-31M | $-26M | $-28M | $-34M | $-38M | $-31M | $-30M | $-31M | $-34M | $-31M | |
| Interest Expense | · | · | · | · | · | · | · | · | $9M | $6M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | $722.0K | $511.0K | $607.0K | $553.0K | $613.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $1M | $658.0K | |
| Other Non-op | $-32M | $16M | $-10M | $-7M | $-2M | $20M | $10M | $4M | $14M | $196.0K | $-211.0K | $89.0K | $30.0K | $-264.0K | $-13.0K | $16.0K | |
| Pretax Income | $-67M | $-22M | $-102M | $-33M | $-37M | $-23M | $-31M | $-32M | $24M | $-37M | $-42M | $-34M | $-33M | $-34M | $-38M | $-36M | |
| Income Tax | $0 | $1.0K | $-67.0K | $34.0K | $40.0K | $36.0K | $-109.0K | $28.0K | $67.0K | $71.0K | $130.0K | $12.0K | $127.0K | $54.0K | $73.0K | $45.0K | |
| Net Income | $-67M | $-22M | $-102M | $-33M | $-37M | $-23M | $-31M | $-32M | $24M | $-37M | $-42M | $-35M | $-33M | $-34M | $-39M | $-36M | |
| EPS (Basic) | $-2.32 | $-1.02 | $-7.02 | $-3.82 | $-4.32 | $-2.77 | $-2.97 | $-3.85 | $2.26 | $-4.85 | $-17.90 | $-0.30 | $-0.29 | $-0.30 | $-0.42 | $-0.45 | |
| EPS (Diluted) | $-2.32 | $-1.24 | $-7.02 | $-3.82 | $-4.32 | $-2.77 | $-2.33 | $-3.85 | $-2.97 | $-4.85 | $-17.90 | $-0.30 | $-0.29 | $-0.30 | $-0.42 | $-0.45 | |
| Shares (Basic) | 28,938 | 22,014 | · | 8,669 | 8,620 | 8,470 | · | 8,336 | 8,069 | 7,700 | · | 114,401 | 114,207,000 | 113,481,000 | · | 80,210,000 | |
| Shares (Diluted) | 28,938 | 24,715 | · | 8,669 | 8,620 | 8,470 | · | 8,336 | 10,295 | 7,700 | · | 114,401 | 114,207,000 | 113,481,000 | · | 80,210,000 | |
| EBITDA | · | $-27M | · | $-15M | $-24M | $-33M | · | $-26M | $-28M | $-34M | · | $-31M | $-30M | $-31M | · | $-31M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $55M | $91M | $61M | $38M | $39M | $39M | $62M | $73M | $85M | $31M | $52M | $44M | $81M | $84M | $135M | $71M | |
| Receivables | $30M | $23M | $26M | $32M | $33M | $35M | $31M | $32M | $38M | $31M | · | $38M | $32M | $35M | · | $27M | |
| Inventory | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $3M | $3M | · | $3M | $4M | $4M | · | $4M | |
| Prepaid Expense | $7M | $9M | $9M | $8M | $8M | $10M | $12M | $15M | $15M | $15M | · | $13M | $18M | $18M | · | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $31M | |
| Current Assets | $106M | $126M | $103M | $90M | $98M | $120M | $156M | $185M | $209M | $198M | · | $263M | $291M | $319M | · | $223M | |
| PP&E (Net) | $94.0K | $91.0K | $104.0K | $122.0K | $244.0K | $322.0K | $400.0K | $495.0K | $628.0K | $719.0K | · | $686.0K | $766.0K | $849.0K | · | $1M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $111M | $131M | $108M | $96M | $105M | $128M | $164M | $189M | $214M | $204M | · | $270M | $298M | $326M | · | $231M | |
| Accounts Payable | $8M | $4M | $4M | $5M | $3M | $6M | $5M | $6M | $3M | $5M | · | $943.0K | $2M | $9M | · | $813.0K | |
| Accrued Liabilities | $79M | $76M | $64M | $66M | $63M | $57M | $61M | $50M | $50M | $55M | · | $56M | $52M | $47M | · | $56M | |
| Current Liabilities | $134M | $117M | $92M | $87M | $99M | $90M | $92M | $61M | $58M | $65M | · | $62M | $59M | $62M | · | $62M | |
| Capital Leases | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $0 | $955.0K | $2M | · | $4M | $4M | $5M | · | $7M | |
| Other Non-current Liabilities | $336.0K | $278.0K | $11M | $14M | $8M | $5M | $2M | $6M | $4M | $3M | · | $1M | $2M | $1M | · | · | |
| Total Liabilities | $441M | $397M | $401M | $365M | $344M | $334M | $350M | $349M | $346M | $373M | · | $370M | $369M | $371M | · | $372M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | · | $12.0K | $12.0K | $12.0K | · | $8.0K | |
| Retained Earnings | $-1.85B | $-1.78B | $-1.76B | $-1.66B | $-1.62B | $-1.59B | $-1.56B | $-1.53B | $-1.50B | $-1.52B | · | $-1.45B | $-1.41B | $-1.38B | · | $-1.31B | |
| AOCI | $41.0K | $43.0K | $71.0K | $-259.0K | $-251.0K | $-321.0K | $-356.0K | $-222.0K | $-605.0K | $-518.0K | · | $-742.0K | $-783.0K | $-419.0K | · | $-752.0K | |
| Stockholders' Equity | $-330M | $-266M | $-293M | $-269M | $-239M | $-206M | $-186M | $-160M | $-132M | $-169M | $-136M | $-100M | $-71M | $-45M | $-17M | $-140M | |
| Liabilities + Equity | $111M | $131M | $108M | $96M | $105M | $128M | $164M | $189M | $214M | $204M | · | $270M | $298M | $326M | · | $231M | |
| Shares Outstanding | 22,680,000 | 22,544,000 | 18,311,000 | 8,702,000 | 8,647,000 | 8,568,000 | 8,413,000 | 125,303,000 | 124,635,000 | 116,457,000 | · | 114,523,000 | 114,340,000 | 113,971,000 | · | 81,027,000 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $5M | $6M | $7M | |
| Operating Cash Flow | $-25M | $-23M | $-12M | $-6M | $-19M | $-39M | $-26M | $-19M | $-38M | $-44M | $-19M | $-30M | $-26M | $-19M | $-27M | $-28M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $-53.0K | $0 | $0 | $195.0K | $0 | $0 | $0 | $0 | $0 | $39.0K | |
| Investing Cash Flow | $-10M | $3M | $5M | $5M | $18M | $15M | $15M | $7M | $51M | $22M | $27M | $-8M | $21M | $-32M | $-65M | $12M | |
| Stock Issued | $0 | $20M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $20M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-898.0K | $50M | $30M | $0 | $356.0K | $0 | $680.0K | $0 | · | · | $264.0K | $0 | $860.0K | $0 | $156M | $6M | |
| Net Change in Cash | $-36M | $30M | $23M | $-1M | $-48.0K | $-24M | $-10M | $-12M | $54M | $-22M | $9M | $-37M | $-4M | $-51M | $64M | $-11M | |
| Free Cash Flow | · | · | · | · | · | $-39M | · | · | · | $-44M | · | · | · | $-19M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-50M | · | · | · | $-25M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -76.3% | · | -34.6% | -64.3% | -110.8% | · | -67.8% | -65.7% | -101.9% | · | -86.8% | -78.7% | -79.8% | · | -85.3% | |
| Net Margin | · | -63.9% | · | -75.2% | -98.2% | -78.2% | · | -82.7% | 55.6% | -112.8% | · | -95.8% | -86.8% | -88.2% | · | -100.5% | |
| Pretax Margin | · | -63.8% | · | -75.1% | -98.1% | -78.0% | · | -82.6% | 55.8% | -112.6% | · | -95.8% | -86.5% | -88.0% | · | -100.4% | |
| EBITDA Margin | · | -76.3% | · | -34.6% | -64.3% | -110.8% | · | -67.8% | -65.7% | -101.9% | · | -86.8% | -78.7% | -79.8% | · | -85.3% | |
| ROA | · | -17.3% | · | -23.2% | -23.4% | -14.1% | · | -14.0% | 9.3% | -14.1% | · | -13.8% | -11.8% | -11.0% | · | -15.0% | |
| ROE | · | 9.5% | · | 15.4% | 20.1% | 12.5% | · | 24.7% | -23.4% | 34.9% | · | 28.7% | 34.8% | 53.2% | · | 27.3% | |
| ROIC | · | 10.1% | · | 5.7% | 10.2% | 16.2% | · | 16.5% | 21.2% | 20.0% | · | 31.1% | 41.7% | 68.5% | · | 22.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | · | 1.0 | 1.0 | 1.3 | · | 3.0 | 3.6 | 3.0 | · | 4.2 | 4.9 | 5.2 | · | 3.6 | |
| Quick Ratio | · | 1.0 | · | 0.8 | 0.7 | 0.8 | · | 1.7 | 2.1 | 0.9 | · | 1.3 | 1.9 | 1.9 | · | 1.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -3.1 | -5.7 | · | -5.1 | -5.1 | -5.4 | · | -5.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | · | 1.2 | · | 1.4 | 1.1 | 0.9 | · | 1.1 | 1.2 | 1.0 | · | 1.1 | 1.3 | 1.3 | · | 1.6 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-11.78 | · | $-30.94 | $-27.63 | $-24.03 | · | $-1.27 | $-1.06 | $-1.45 | · | $-0.88 | $-0.62 | $-0.40 | · | $-1.73 | |
| Revenue / Share | · | $1418.81 | · | $5080.63 | $4400.12 | $3543.68 | · | $310.24 | $0.28 | $0.29 | · | $0.31 | $0.33 | $0.34 | · | $0.45 | |
| Cash Flow / Share | · | $-919.60 | · | · | · | $-4602.60 | · | · | · | $-0.38 | · | · | · | $-0.17 | · | · | |
| Cash / Share | · | $4.03 | · | $4.33 | $4.48 | $4.53 | · | $0.58 | $0.68 | $0.26 | · | $0.38 | $0.71 | $0.74 | · | $0.88 | |
| EPS (TTM) | $-12.15 | $-16.40 | · | $-13.24 | $-13.27 | $-11.92 | · | $-29.57 | $-26.02 | $-23.34 | · | $-1.31 | $-1.46 | $-1.79 | · | $-1.08 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $147M | $151M | · | $143M | $137M | $142M | · | $148M | $146M | $140M | · | $146M | $146M | $148M | · | $250M | |
| Net Income TTM | $-116M | $-195M | · | $-125M | $-124M | $-63M | · | $-87M | $-90M | $-146M | · | $-140M | $-142M | $-158M | · | $-88M | |
| Market Cap | · | $126M | · | $57M | $37M | $32M | · | $1.56B | $1.62B | $2.64B | · | $2.30B | $3.07B | $6.65B | · | $6.64B | |
| P/E | -0.8 | -0.3 | · | -0.5 | -0.3 | -0.3 | · | -0.4 | -0.5 | -1.0 | · | -15.3 | -18.4 | -32.6 | · | -75.8 | |
| P/S | · | 0.8 | · | 0.4 | 0.3 | 0.2 | · | 10.5 | 11.1 | 18.8 | · | 15.8 | 21.0 | 44.9 | · | 26.6 | |
| P/B | · | -0.5 | · | -0.2 | -0.2 | -0.2 | · | -9.8 | -12.3 | -15.6 | · | -22.9 | -43.1 | -147.2 | · | -47.3 | |
| P / Cash Flow | · | -5.5 | · | · | · | -0.8 | · | · | · | -60.3 | · | · | · | -351.7 | · | · | |
| Earnings Yield | -147.4% | -294.4% | · | -202.5% | -307.9% | -318.7% | · | -237.5% | -199.8% | -103.0% | · | -6.5% | -5.4% | -3.1% | · | -1.3% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $146M | $145M | $146M | $157M | $210M |
| Faaliyet Kâr Marjı % | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% |
| Net Gelir | $-196M | $-76M | $-143M | $-165M | $-124M |
| Seyreltilmiş Hisse Başı Kâr | $-17.93 | $-14.00 | $-18.79 | $-2.02 | $-1.65 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 1.1 | 1.7 | 3.4 | 5.3 | 3.7 |
| Cari Oran | 0.9 | 1.0 | 1.1 | 2.8 | 2.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-75M | $-128M | $-93M | $-150M | $-107M |
Kurumsal Sahipler (13F) 112 dosya · $215.6M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
112
Tutulan Değer
$215.6M
Yeni pozisyonlar
39
Çıkan pozisyonlar
17
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 39 (-2 önceki Ç'ye göre) | 17 (+4 önceki Ç'ye göre) | 32 (-5 önceki Ç'ye göre) | 20 (+11 önceki Ç'ye göre) | -2.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18.732.549 | 1.917.354 | 8,69% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14.863.316 | 1.521.322 | 6,89% | Hisse senetleri |
| ACORN CAPITAL ADVISORS, LLC | $14.831.964 | 1.518.113 | 6,88% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $13.918.908 | 1.424.658 | 6,46% | Hisse senetleri |
| BlackRock, Inc. | $13.861.666 | 1.418.799 | 6,43% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.369.225 | 958.979 | 4,35% | Hisse senetleri |
| Catalio Capital Management, LP | $9.192.153 | 940.855 | 4,26% | Hisse senetleri |
| Avidity Partners Management LP | $9.032.238 | 924.487 | 4,19% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $6.792.729 | 695.264 | 3,15% | Hisse senetleri |
| Kalehua Capital Management LLC | $6.698.742 | 685.644 | 3,11% | Hisse senetleri |
| NEA Management Company, LLC | $5.635.141 | 576.780 | 2,61% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $5.191.417 | 531.231 | 2,41% | Hisse senetleri |
| Ghisallo Capital Management LLC | $4.885.000 | 500.000 | 2,27% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.736.496 | 484.800 | 2,20% | Alım opsiyonu |
| Soleus Capital Management, L.P. | $4.298.800 | 440.000 | 1,99% | Hisse senetleri |
| VANGUARD GROUP INC | $4.118.796 | 559.619 | 1,91% | Hisse senetleri |
| UBS Group AG | $3.454.135 | 353.545 | 1,60% | Hisse senetleri |
| STATE STREET CORP | $3.184.932 | 325.991 | 1,48% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $3.053.125 | 312.500 | 1,42% | Hisse senetleri |
| Brevan Howard Capital Management LP | $3.026.912 | 309.817 | 1,40% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $2.986.455 | 305.676 | 1,39% | Hisse senetleri |
| Boxer Capital Management, LLC | $2.955.777 | 302.536 | 1,37% | Hisse senetleri |
| Davidson Kempner Capital Management LP | $2.931.000 | 300.000 | 1,36% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $2.906.184 | 297.460 | 1,35% | Hisse senetleri |
| Caption Management, LLC | $2.791.289 | 285.700 | 1,29% | Alım opsiyonu |
| Eversept Partners, LP | $2.698.220 | 276.174 | 1,25% | Hisse senetleri |
| Tetragon Partners GP Ltd | $2.445.431 | 250.300 | 1,13% | Alım opsiyonu |
| JPMORGAN CHASE & CO | $2.093.737 | 207.609 | 0,97% | Hisse senetleri |
| MORGAN STANLEY | $1.978.485 | 202.506 | 0,92% | Hisse senetleri |
| Trexquant Investment LP | $1.840.355 | 188.368 | 0,85% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $1.837.131 | 188.038 | 0,85% | Hisse senetleri |
| BARCLAYS PLC | $1.620.882 | 165.904 | 0,75% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.563.258 | 160.006 | 0,73% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.420.568 | 145.401 | 0,66% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.317.172 | 134.818 | 0,61% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.254.967 | 128.451 | 0,58% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.057.251 | 108.214 | 0,49% | Hisse senetleri |
| DLD Asset Management, LP | $989.625 | 101.500 | 0,46% | Satım opsiyonu |
| SILVERBACK ASSET MANAGEMENT LLC | $977.000 | 100.000 | 0,45% | Alım opsiyonu |
| Jump Financial, LLC | $918.380 | 94.000 | 0,43% | Hisse senetleri |
| Caption Management, LLC | $903.725 | 92.500 | 0,42% | Satım opsiyonu |
| Invesco Ltd. | $882.270 | 90.304 | 0,41% | Hisse senetleri |
| DLD Asset Management, LP | $780.975 | 80.100 | 0,36% | Alım opsiyonu |
| Connor, Clark & Lunn Investment Management Ltd. | $746.399 | 76.397 | 0,35% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $702.199 | 71.873 | 0,33% | Hisse senetleri |
| J. Goldman & Co LP | $660.452 | 67.600 | 0,31% | Satım opsiyonu |
| TWO SIGMA ADVISERS, LP | $660.405 | 89.729 | 0,31% | Hisse senetleri |
| J. Goldman & Co LP | $659.475 | 67.500 | 0,31% | Hisse senetleri |
| Squarepoint Ops LLC | $623.336 | 63.801 | 0,29% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $605.183 | 61.943 | 0,28% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| James J. Bochnowski (“Bochnowski”), David L. Douglass (“Douglass”), Deepika R. Pakianathan (“Pakianathan”), Douglas A. Roeder (“Roeder”) ×3 başvurular | 07 Haziran 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 33 içeriden öğrenenler · 20 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Richard A. Paulson | President and CEO | 14 Mayıs 2026 S | 269.747 | 0 | 2 | $-137.245 |
| Lori Macomber | EVP, CFO & Treasurer | 03 Şubat 2026 S | 85.105 | 0 | 1 | $-10.244 |
| Michael Mason | EVP, CFO & Treasurer | 04 Eylül 2024 S | 391.054 | 0 | 0 | $0 |
| Michael Falvey | EVP, CFO & Treasurer | 24 Ocak 2018 A | · | 0 | 0 | $0 |
| Justin A Renz | EVP, CFO & Treasurer | 20 Ocak 2017 A | 19.173 | 0 | 0 | $0 |
| Kristin Abate | Chief Accounting Officer | 01 Ekim 2026 S | 23.404 | 0 | 6 | $-8.183 |
| Stuart Poulton | EVP, Chief Development Officer | 28 Temmuz 2026 S | 94.632 | 0 | 4 | $-56.432 |
| Sohanya Roshan Cheng | EVP & Chief Commercial Officer | 14 Mayıs 2026 S | 107.940 | 0 | 2 | $-46.402 |
| Michael Mano | EVP, CLO&Secretary | 14 Mayıs 2026 S | 94.398 | 0 | 2 | $-35.707 |
| Reshma Rangwala | EVP & Chief Medical Officer | 14 Mayıs 2026 S | 56.829 | 0 | 3 | $-55.561 |
| Stephen Mitchener | SVP, Chief Business Officer | 01 Mart 2023 S | 128.313 | 0 | 0 | $0 |
| Sharon Shacham | Chief Scientific Officer | 29 Mart 2022 A | 958.131 | 0 | 0 | $0 |
| Ran Frenkel | EVP, Chief Dev. Officer | 28 Şubat 2022 A | 168.290 | 0 | 0 | $0 |
| Jatin Shah | EVP, Chief Medical Officer | 17 Şubat 2022 S | 129.450 | 0 | 0 | $0 |
| John Demaree | Chief Commercial Officer | 25 Şubat 2021 A | 23.995 | 0 | 0 | $0 |
| Tanya Lewis | EVP, Chief Reg. Affairs | 25 Şubat 2021 A | 45.401 | 0 | 0 | $0 |
| Christopher Brett Primiano | EVP, CBO, GC & Secretary | 01 Aralık 2020 M | 4.523 | 0 | 0 | $0 |
| Cameron Peters | VP of Finance | 15 Şubat 2019 A | · | 0 | 0 | $0 |
| Anand Varadan | EVP, Chief Commercial Officer | 15 Şubat 2019 A | · | 0 | 0 | $0 |
| Paul Brannelly | SVP, FINANCE & ADMIN, TREAS | 15 Mayıs 2014 P | 66.136 | 0 | 0 | $0 |
| Zhen Su | Yönetim kurulu üyesi | 21 Mayıs 2026 A | 15.508 | 0 | 0 | $0 |
| Christy J. Oliger | Yönetim kurulu üyesi | 21 Mayıs 2026 A | 15.508 | 0 | 0 | $0 |
| Mansoor Raza Mirza | Yönetim kurulu üyesi | 28 Mayıs 2025 A | 0 | 0 | 0 | $0 |
| Peter Honig | Yönetim kurulu üyesi | 24 Mayıs 2023 A | · | 0 | 0 | $0 |
| Michael Kauffman | Yönetim kurulu üyesi | 28 Şubat 2022 A | 898.131 | 0 | 0 | $0 |
| Mikael Dolsten | Yönetim kurulu üyesi | 21 Mayıs 2021 A | · | 0 | 0 | $0 |
| Scott J. Garland | Yönetim kurulu üyesi | 06 Haziran 2019 A | · | 0 | 0 | $0 |
| Carsten Thiel | Yönetim kurulu üyesi | 31 Ağustos 2018 A | · | 0 | 0 | $0 |
| Kenneth E Weg | Yönetim kurulu üyesi | 15 Haziran 2017 A | 5.000 | 0 | 0 | $0 |
| Chen Schor | · | 21 Mayıs 2026 A | 15.508 | 0 | 0 | $0 |
| Barry E Greene | · | 21 Mayıs 2026 A | 16.415 | 0 | 0 | $0 |
| Deepika Pakianathan | · | 21 Mayıs 2026 A | 15.508 | 0 | 0 | $0 |
| Garen G Bohlin | · | 21 Mayıs 2026 A | 18.517 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 14 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,22% | 57.877 SH | 02 Ekim 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 35.695 SH | 02 Ekim 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 115.151 SH | 19 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14.746 SH | 19 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,01% | 66.498 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 9.500 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 481.328 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 31.663 SH | 02 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,00% | 27.942 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 263.084 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 677.729 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.188 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.733 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 152.603 SH | 11 Eylül 2026 | Günlük |
KPTI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$7.50
+834,9%
3 27,3%
Güçlü Al
6 54,5%
Al
2 18,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-09-30Ortalama hedef $7.25 +803,8%
← Tüm hedeflerin altında
Mevcut fiyat $0.80
Düşük$3.00
Ortalama$7.25
Yüksek$11.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | · |
| ACTU | $142M | -5.8 | · | · | -843.5% | · |
| JSPR | · | -0.5 | · | · | · | · |
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| DYAI | · | -4.1 | -11.6% | · | · | · |
| CLRB | · | -0.4 | · | · | · | · |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | · |
| KTTA | · | · | · | · | · | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026